Medigen Vaccine (Taiwan) Market Value
6547 Stock | TWD 38.50 0.20 0.52% |
Symbol | Medigen |
Medigen Vaccine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medigen Vaccine's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medigen Vaccine.
10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Medigen Vaccine on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Medigen Vaccine Biologics or generate 0.0% return on investment in Medigen Vaccine over 30 days. Medigen Vaccine is related to or competes with OBI Pharma, Tanvex BioPharma, and Adimmune Corp. Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccin... More
Medigen Vaccine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medigen Vaccine's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medigen Vaccine Biologics upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.33) | |||
Maximum Drawdown | 7.39 | |||
Value At Risk | (2.96) | |||
Potential Upside | 1.91 |
Medigen Vaccine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medigen Vaccine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medigen Vaccine's standard deviation. In reality, there are many statistical measures that can use Medigen Vaccine historical prices to predict the future Medigen Vaccine's volatility.Risk Adjusted Performance | (0.18) | |||
Jensen Alpha | (0.38) | |||
Total Risk Alpha | (0.58) | |||
Treynor Ratio | (1.51) |
Medigen Vaccine Biologics Backtested Returns
Medigen Vaccine Biologics has Sharpe Ratio of -0.24, which conveys that the firm had a -0.24% return per unit of risk over the last 3 months. Medigen Vaccine exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medigen Vaccine's Standard Deviation of 1.44, mean deviation of 1.12, and Risk Adjusted Performance of (0.18) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.23, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medigen Vaccine's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medigen Vaccine is expected to be smaller as well. At this point, Medigen Vaccine Biologics has a negative expected return of -0.35%. Please make sure to verify Medigen Vaccine's market risk adjusted performance, coefficient of variation, information ratio, as well as the relationship between the mean deviation and standard deviation , to decide if Medigen Vaccine Biologics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.12 |
Insignificant predictability
Medigen Vaccine Biologics has insignificant predictability. Overlapping area represents the amount of predictability between Medigen Vaccine time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medigen Vaccine Biologics price movement. The serial correlation of 0.12 indicates that less than 12.0% of current Medigen Vaccine price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.12 | |
Spearman Rank Test | -0.19 | |
Residual Average | 0.0 | |
Price Variance | 0.62 |
Medigen Vaccine Biologics lagged returns against current returns
Autocorrelation, which is Medigen Vaccine stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medigen Vaccine's stock expected returns. We can calculate the autocorrelation of Medigen Vaccine returns to help us make a trade decision. For example, suppose you find that Medigen Vaccine has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Medigen Vaccine regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medigen Vaccine stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medigen Vaccine stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medigen Vaccine stock over time.
Current vs Lagged Prices |
Timeline |
Medigen Vaccine Lagged Returns
When evaluating Medigen Vaccine's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medigen Vaccine stock have on its future price. Medigen Vaccine autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medigen Vaccine autocorrelation shows the relationship between Medigen Vaccine stock current value and its past values and can show if there is a momentum factor associated with investing in Medigen Vaccine Biologics.
Regressed Prices |
Timeline |
Pair Trading with Medigen Vaccine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medigen Vaccine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will appreciate offsetting losses from the drop in the long position's value.Moving together with Medigen Stock
Moving against Medigen Stock
0.95 | 2881A | Fubon Financial Holding | PairCorr |
0.92 | 2891 | CTBC Financial Holding | PairCorr |
0.87 | 2891B | CTBC Financial Holding | PairCorr |
0.86 | 2882B | Cathay Financial Holding | PairCorr |
0.79 | 4162 | PharmaEngine | PairCorr |
The ability to find closely correlated positions to Medigen Vaccine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medigen Vaccine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medigen Vaccine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medigen Vaccine Biologics to buy it.
The correlation of Medigen Vaccine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medigen Vaccine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medigen Vaccine Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medigen Vaccine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Medigen Stock Analysis
When running Medigen Vaccine's price analysis, check to measure Medigen Vaccine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigen Vaccine is operating at the current time. Most of Medigen Vaccine's value examination focuses on studying past and present price action to predict the probability of Medigen Vaccine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigen Vaccine's price. Additionally, you may evaluate how the addition of Medigen Vaccine to your portfolios can decrease your overall portfolio volatility.